Facebook tracking pixel
R59.0
ICD-10-CM
Axillary Mass

Axillary mass, also known as an axillary lump or lump in armpit, requires proper clinical documentation and medical coding for accurate diagnosis. This page provides information on healthcare considerations for axillary masses, including differential diagnoses, evaluation, and relevant medical coding terms for optimal patient care and accurate billing. Learn about the causes of axillary lumps, diagnostic workup, and when to seek medical attention for an armpit mass.

Also known as

Axillary Lump
Lump in Armpit

Diagnosis Snapshot

Key Facts
  • Definition : Enlarged tissue or swelling in the armpit, which can be painful or painless.
  • Clinical Signs : Palpable lump, swelling, pain, skin changes, limited arm movement.
  • Common Settings : Primary care, oncology, surgery, breast clinic, dermatology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC R59.0 Coding
R22.2

Localized swelling, mass and lump, axilla

Describes a lump, mass, or swelling specifically located in the armpit.

C77.0-C77.9

Secondary malignant neoplasm of lymph nodes

Indicates cancerous spread to lymph nodes, which can present as axillary masses.

N60-N64

Disorders of breast

Breast conditions, some of which may cause axillary lymph node enlargement.

R59.0

Localized lymphadenopathy

Swollen lymph nodes anywhere in the body, potentially including the armpit.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the axillary mass inflammatory/infective?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Swollen lymph nodes in the armpit.
Enlarged lymph nodes, any location.
Localized collection of pus in the armpit.

Documentation Best Practices

Documentation Checklist
  • Document mass location (L/R), size, shape, mobility.
  • Note tenderness, skin changes, nipple discharge.
  • Describe associated symptoms (pain, fever, etc.).
  • Record family history of breast cancer.
  • Include relevant imaging/biopsy results.

Coding and Audit Risks

Common Risks
  • Laterality Documentation

    Missing documentation specifying right, left, or bilateral axillary mass impacts code selection and reimbursement.

  • Mass Evaluation Specificity

    Lack of detail about the mass characteristics (size, consistency, mobility) may lead to unspecified coding and affect clinical documentation integrity.

  • Differential Diagnosis Coding

    If other possible diagnoses are considered, they must be documented for accurate coding and to support medical necessity of further workup.

Mitigation Tips

Best Practices
  • Thorough physical exam: palpation, size, mobility documentation. ICD-10: R22.3
  • Image if >2cm or fixed: ultrasound, mammogram. SNOMED CT: 263502005
  • Assess for infection, inflammation: CBC, CRP. LOINC: 742-7
  • Biopsy if suspicious: FNA, core needle. CPT: 10021, 10022
  • Correlate findings with patient history, medications, risk factors. CDI best practice

Clinical Decision Support

Checklist
  • Confirm laterality (right or left armpit).
  • Document mass size, shape, and mobility.
  • Assess for tenderness, skin changes, nipple discharge.
  • Consider related symptoms (e.g., fever, weight loss).
  • Order appropriate imaging and/or biopsy as needed.

Reimbursement and Quality Metrics

Impact Summary
  • Medical billing reimbursement for axillary mass diagnosis (ICD-10 R22.3) varies based on payer and procedure codes.
  • Coding accuracy crucial for axillary mass cases. Incorrect coding can lead to claim denials and reduced revenue.
  • Hospital reporting of axillary mass cases impacts quality metrics related to diagnosis timeliness and treatment efficacy.
  • Accurate documentation improves reimbursement and quality reporting for axillary lump or armpit lump diagnoses.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What is the initial differential diagnosis workup for a palpable axillary mass in an adult female, and how should imaging be incorporated into the evaluation?

A: The initial differential diagnosis for a palpable axillary mass in an adult female is broad, encompassing benign conditions like fibroadenoma, lipoma, lymphadenopathy (reactive or infectious), hidradenitis suppurativa, and more serious conditions like breast cancer metastasis or lymphoma. The workup should begin with a thorough history and physical exam, focusing on characteristics of the mass (size, mobility, tenderness, consistency), associated symptoms (pain, fever, skin changes), and relevant risk factors (family history of breast cancer, recent infections). Imaging plays a crucial role in further clarifying the diagnosis. Ultrasound is often the first-line imaging modality, particularly helpful in differentiating cystic vs. solid masses. Mammography should also be considered, especially in women over 40 or with any breast-related symptoms. If ultrasound or mammography findings are indeterminate, further evaluation with MRI, fine-needle aspiration (FNA) biopsy, or core needle biopsy may be necessary to obtain a definitive diagnosis. Explore how integrating a standardized imaging protocol can improve diagnostic accuracy in axillary mass evaluation.

Q: When is axillary lymph node dissection indicated in the management of breast cancer, and what are the potential complications clinicians should consider?

A: Axillary lymph node dissection (ALND) is typically indicated in the management of breast cancer when sentinel lymph node biopsy (SLNB) reveals metastatic disease. The presence of positive sentinel nodes suggests a higher risk of further axillary involvement, and ALND helps determine the extent of nodal spread, guiding further treatment decisions (e.g., adjuvant chemotherapy, radiation therapy). However, ALND carries potential complications, including lymphedema, seroma formation, infection, nerve injury (e.g., intercostobrachial nerve), and shoulder dysfunction. The decision to perform ALND must be individualized, carefully weighing the benefits of accurate staging against the potential risks of complications. Consider implementing strategies to mitigate lymphedema risk, such as preoperative lymphatic mapping and minimizing axillary dissection when appropriate. Learn more about the evolving role of ALND in the era of neoadjuvant therapy and personalized breast cancer treatment.

Quick Tips

Practical Coding Tips
  • Code axillary mass laterality
  • Document mass characteristics
  • Rule out lymphadenopathy
  • Check for associated symptoms
  • Consider imaging findings

Documentation Templates

Patient presents with a complaint of an axillary mass, also described as an axillary lump or lump in the armpit.  Onset of the mass is [duration and onset description - e.g., gradual over the past month, sudden onset two days ago].  Location of the mass is specified as [right/left] axilla, [location within axilla - e.g., central, anterior, posterior, superior, inferior].  Patient reports [presence/absence] of pain associated with the mass, described as [character of pain - e.g., sharp, dull, aching, throbbing].  Associated symptoms include [list associated symptoms - e.g.,  breast tenderness, nipple discharge, skin changes, fever, chills, night sweats, weight loss, lymphadenopathy].  Physical examination reveals a [palpable/non-palpable] mass in the [right/left] axilla, measuring approximately [size in cm] in diameter.  The mass is [description of mass - e.g., mobile, fixed, firm, soft, tender, non-tender].  Overlying skin is [description of skin - e.g., normal, erythematous, edematous, ulcerated].  Differential diagnosis includes lymphadenopathy, lipoma, sebaceous cyst, hidradenitis suppurativa, breast cancer metastasis, lymphoma.  Plan includes [diagnostic tests ordered - e.g.,  mammogram, ultrasound, biopsy, complete blood count, comprehensive metabolic panel] and [treatment plan - e.g.,  referral to specialist, follow-up appointment, antibiotic therapy, pain management].  Patient education provided regarding axillary mass evaluation, potential causes, and treatment options.  Patient understands the plan and will return for follow-up as scheduled.